tiprankstipranks
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market

Beam Therapeutics (BEAM) Technical Analysis

Compare
1,352 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Beam Therapeutics’s (BEAM) Moving Averages Convergence Divergence (MACD) indicator is 1.77, suggesting Beam Therapeutics is a Sell.
Beam Therapeutics’s (BEAM) 20-Day exponential moving average is 28.92, while Beam Therapeutics’s (BEAM) share price is $33.14, making it a Buy.
Beam Therapeutics’s (BEAM) 50-Day exponential moving average is 27.37, while Beam Therapeutics’s (BEAM) share price is $33.14, making it a Buy.

Beam Therapeutics (BEAM) Pivot Points

Feb 21, 2025, 11:41 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
31.50
32.31
33.20
34.01
34.90
35.71
36.60
Fibonacci
32.31
32.96
33.36
34.01
34.66
35.06
35.71
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Beam Therapeutics (BEAM) Moving Averages

Feb 21, 2025, 11:41 AM
Period
Simple
Exponential
MA5
32.35Buy
32.28Buy
MA10
29.88Buy
30.63Buy
MA20
28.02Buy
28.92Buy
MA50
27.18Buy
27.37Buy
MA100
25.95Buy
26.70Buy
MA200
25.54Buy
26.81Buy
Beam Therapeutics’s (BEAM) 10-Day exponential moving average is 30.63, while Beam Therapeutics’s (BEAM) share price is $33.14, making it a Buy.
Beam Therapeutics’s (BEAM) 100-Day exponential moving average is 26.70, while Beam Therapeutics’s (BEAM) share price is $33.14, making it a Buy.
Beam Therapeutics’s (BEAM) stock price is $33.14 and Beam Therapeutics’s (BEAM) 50-day simple moving average is 27.18, creating a Buy signal.
Beam Therapeutics’s (BEAM) stock price is $33.14 and Beam Therapeutics’s (BEAM) 100-day simple moving average is 25.95, creating a Buy signal.
Beam Therapeutics’s (BEAM) stock price is $33.14 and Beam Therapeutics’s (BEAM) 200-day simple moving average is 25.54, creating a Buy signal.

Beam Therapeutics (BEAM) Technical Indicators

Feb 21, 2025, 11:41 AM
Name
Value
Implied Action
RSI (14)
69.89
Neutral
STOCH (9,6)
83.06
Sell
STOCHRSI (14)
84.65
Sell
MACD (12,26)
1.77
Sell
ADX (14)
21.88
Neutral
Williams %R
-19.31
Sell
CCI (14)
168.31
Sell
ATR (14)
2.01
-
Ultimate Oscillator
57.81
Neutral
ROC
21.48
Buy
Beam Therapeutics’s (BEAM) Relative Strength Index (RSI) is 69.89, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Trend Strength Indicator (ADX) is 21.88, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Commodity Channel Index (CCI) is 168.31, creating a Sell signal.
Beam Therapeutics’s (BEAM) Price Rate of Change (ROC) is 21.48, creating a Buy signal.

FAQ

Is BEAM a Buy, Hold, or Sell?
Based on BEAM’s technical indicators, BEAM is a Buy.
    What is BEAM’s RSI (14)?
    BEAM’s RSI (14) is 69.89, which suggests BEAM is a Neutral.
      What is BEAM’s MACD?
      BEAM’s MACD is 1.77, which suggests BEAM is a Sell.
        What is BEAM’s 5-day moving average?
        BEAM’s 5-day moving average is 32.35, which suggests BEAM is a Buy.
          What is BEAM’s 20-day moving average?
          BEAM 20-day moving average is 28.02, which suggests BEAM is a Buy.
            What is BEAM’s 50-day moving average?
            BEAM’s 50-day moving average is 27.18, which suggests BEAM is a Buy.
              What is BEAM’s 200-day moving average?
              BEAM’s 200-day moving average is 25.54, which suggests BEAM is a Buy.
                What is BEAM’s Williams % R (14)?
                BEAM’s Williams % R (14) is -19.31, which suggests BEAM is a Sell.
                  What is BEAM’s CCI (14)?
                  BEAM’s CCI (14) is 168.31, which suggests BEAM is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis